Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Synergy CHC's revenue for the
three
months ended in Mar. 2026 was $5.49 Mil.
Its revenue for the trailing twelve months (TTM) ended in Mar. 2026 was $27.70 Mil.
Synergy CHC's Revenue per Share for the
three
months ended in Mar. 2026 was $0.49.
Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $2.73.
Warning Sign:
Synergy CHC Corp revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of Synergy CHC was -35.50% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -7.00% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -4.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 11 years, Synergy CHC's highest 3-Year average Revenue per Share Growth Rate was 1580.60% per year. The lowest was -8.50% per year. And the median was 3.75% per year.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Synergy CHC Revenue Related Terms
Synergy CHC Revenue Historical Data
* Premium members only.
The historical data trend for Synergy CHC's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Synergy CHC's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Synergy CHC Revenue vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Synergy CHC's Revenue distribution charts can be found below:
* The bar in red indicates where Synergy CHC's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $27.70 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Synergy CHC (SNYR) has a Revenue of $27.70 Mil as of Mar. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Synergy CHC and its competitors.
Is Synergy CHC's Revenue too high?
Synergy CHC's current Revenue is $27.70 Mil.
How does Synergy CHC's Revenue compare to MEDS and MCK?
Synergy CHC's Revenue of $27.70 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Medical Distribution company?
A good Revenue depends on the Medical Distribution industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Synergy CHC and its competitors. Synergy CHC's current Revenue is $27.70 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synergy CHC stock overvalued right now?
Based on GuruFocus' analysis, Synergy CHC (SNYR) is currently considered Possible Value Trap. The stock's GF Value™ is $1.08, compared to a current price of $0.11 — trading 90% below its estimated fair value. The current Revenue is $27.70 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Synergy CHC (SNYR), the current Revenue is $27.70 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Synergy CHC Corp is a provider of consumer health care, beauty, and lifestyle products. It is engaged in the business of marketing and distributing consumer-branded products through various distribution channels in the health and wellness industry. The company's products include FOCUSfactor, Flat Tummy Tea, Hand MD, and Neuragen, amongst others. Flat Tummy is a lifestyle and wellness brand that provides a suite of nutritional products to help women achieve their nutrition and weight management goals.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SNYR has been successfully added to your 
